The EIF2A locus is amplified in patients with lung and head and neck squamous cell carcinoma (SCC) as well as esophageal carcinoma (3), and elevated eIF2A levels have been associated with poor prognosis in breast cancer (18). This evidence concerns the gene EIF2A and breast carcinoma.